横向流动分析市场概况、增长、趋势、分析、研究报告(2022-2030 年)

  • Report Code : TIPRE00005544
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 246
Buy Now

Lateral Flow Assay Market Forecast Report | Growth, Size & Share 2030

Buy Now

 

2022 年横向流动分析市场规模价值 85.0589 亿美元,预计到 2030 年将达到 161.0613 亿美元;预计 2022 年至 2030 年的复合年增长率为 8.4%。

 

市场洞察和分析师观点:

横向流动免疫测定,也称为免疫色谱测定或试纸条测试,是一种易于使用的诊断工具,可用于确定目标分析物(例如人类或动物中的病原体或生物标志物)是否存在。由于横向流动测定易于使用、经济高效且可检测样本中的多种标志物,因此它们在治疗药物监测中越来越受欢迎。此外,传染病的日益流行和主要市场参与者的投资不断增加推动了横向流动测定市场的增长。此外,由于对横向流动测定试剂盒、家庭和 POC 测试的需求不断增加,各种诊断测试的可用性不断提高,从而促进了市场的增长。

 

增长动力:

横向流动检测 (LFA) 是一种纸质测试,用于检测复杂混合物(生物样本)中的分析物(特定条件的生物分子),其中样本被放置在测试设备中的指定位置。这些测试可在 5-30 分钟内提供结果。横向流动检测试剂盒在各种环境条件下都表现出稳定性,并且保质期更长。基于后续流动检测的家庭测试允许用户测试自行采集的样本并获得结果,而无需经过培训的医疗专业人员的协助。这些测试通常是柜台销售的。妊娠检测试剂盒是家庭横向流动检测最常见的例子之一。此外,这些检测还用于诊断传染病、心血管疾病和 HIV 等耻辱性疾病。因此,这些疾病的患病率不断上升,以及家庭医疗保健中横向流动检测测试的日益普及推动了横向流动检测市场的增长。在 COVID-19 大流行期间,由于人们不愿意去医院或诊断实验室进行检测,许多公司引入了家用横向流动检测法来诊断 SARS-CoV-2 感染。

  • 2020年10月,西门子医疗推出了CLINITEST快速COVID-19抗原自检,可在15分钟内检测出感染情况,以便尽早隔离感染者,避免COVID-19的传播。
  • 2020 年 7 月,BD 推出了一款便携式快速即时抗原检测,可在 15 分钟内检测出 SARS-CoV-2 感染。
  • 2020 年 8 月,美国食品药品管理局 (FDA) 为 Abbott BinaxNOW COVID-19 Ag Card 颁发了紧急使用授权,这是一种用于检测 SARS-CoV-2 的快速检测方法。BinaxNOW 采用 Abbott 久经考验的横向流动技术,使其成为医疗服务提供者进行频繁大规模检测的一种友好而可靠的方法。
  • 2020 年 9 月,罗氏面向接受 CE 标志的市场推出了 SARS-CoV-2 快速抗原检测。  

 

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

横向流动分析市场:

横向流动分析市场
  • Lateral Flow Assay Market
    复合年增长率(2022 - 2030 年)
    8.4%
  • 2022 年市场规模
    85.1 亿美元
  • 2030 年市场规模
    161.1 亿美元

市场动态

增长动力
  • 增加家庭检测试剂盒的使用
未来的趋势
  • 智能手机的使用和横向流动免疫分析中的人工智能集成
机会
  • 横向流动分析的应用发展

关键人物;主力;重要一员

  •  
  • 雅培实验室
  • F.霍夫曼-罗氏有限公司
  • 赛默飞世尔科技公司
  • Bio-Rad 实验室有限公司
  • 生物梅里埃公司
  • Quidel 公司
  • 霍洛吉奇公司
  • 珀金埃尔默公司
  • 默克公司

区域概况

Lateral Flow Assay Market
  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

Lateral Flow Assay Market产品类别
  • 试剂盒、试剂和横向流动读数仪
Lateral Flow Assay Market技术
  • 夹心试验
  • 竞争性检测
  • 多重检测分析
Lateral Flow Assay Market测试类型
  • 横向流动免疫分析和核酸横向流动分析
Lateral Flow Assay Market应用
  • 临床试验
  • 兽医诊断
  • 食品安全及环境检测
  • 药物开发和质量测试
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

报告细分和范围:

横向流动检测市场根据产品类型、技术、检测类型、应用、最终用户和地理位置进行分类。根据产品类型,横向流动检测市场分为试剂盒和试剂以及横向流动读取器。根据技术,横向流动检测市场分为夹层检测、竞争性检测和多重检测检测。根据检测类型,横向流动检测市场分为横向流动免疫测定和核酸横向流动检测。根据应用,横向流动检测市场分为临床检测、兽医诊断、食品安全和环境检测以及药物开发和质量检测。根据最终用户,横向流动检测市场分为医院和诊所、诊断实验室、家庭护理、兽医诊所、制药和生物技术公司等。根据地理位置,横向流动检测市场分为北美(美国、加拿大和墨西哥)、欧洲(法国、德国、英国、西班牙、意大利、比荷卢三国和欧洲其他地区)、亚太地区(中国、印度、日本、澳大利亚、韩国和亚太地区其他地区)、中东和非洲(沙特阿拉伯、阿联酋、南非、科威特、阿曼、卡塔尔、埃及和中东和非洲其他地区)以及南美洲和中美洲(巴西、阿根廷和南美洲和中美洲其他地区)。

 

节段分析:

按产品类型划分,横向流检测市场分为试剂盒和试剂以及横向流读取器。试剂盒和试剂部分在 2022 年占据了更大的市场份额,预计在 2022-2030 年期间市场复合年增长率将更高。随着对试剂盒和试剂的需求大幅增加,横向流检测市场预计将快速增长。许多地区的人畜共患疾病和其他动物疾病都在大幅增加。亚洲和非洲是人畜共患疾病(从动物传播给人类的疾病)的热点地区。根据世界卫生组织 (WHO) 的数据,2012 年至 2022 年期间,非洲爆发了马尔堡病毒病和几种人畜共患疾病。该地区从 2012 年到 2022 年增长了 63%,远高于前十年。此外,人畜共患疾病占 2001-2022 年报告的非洲传染病疫情的约 32%。

因此,全球对动物疾病诊断的需求日益增加。这促使 Thermo Fisher Scientific Inc、Bio-Rad Laboratories, Inc 和 F. Hoffmann-La Roche AG 等公司提供各种试剂和试剂盒,包括 FDA 紧急使用授权的 RT-PCR 检测试剂盒,用于样本采集、病毒核酸分离、鉴定和定量,从而实现可靠和准确的 SARS-CoV-2 检测、抗菌药敏性测试、狂犬病诊断测试和 qPCR。

根据技术,横向流动检测市场分为夹层检测、竞争性检测和多重检测。夹层检测部分在 2022 年占据了最大的市场份额。然而,多重检测分析部分预计将在 2022 年至 2030 年期间录得最高复合年增长率。

按测试类型划分,横向流检测市场分为横向流免疫测定和核酸横向流检测。横向流免疫测定部分在 2022 年占据了更大的市场份额,预计在 2022 年至 2030 年期间市场复合年增长率会更高。横向流免疫测定,也称为免疫色谱测定或试纸条测试,是一种易于使用的诊断工具,用于确定目标分析物(例如人类或动物中的病原体或生物标志物)是否存在。横向流免疫测定测试在减少 COVID-19 疫情的影响方面发挥了关键作用,因为它们能够快速检测受感染的个体并阻止 SARS-CoV-2 进一步传播。横向流免疫测定部分在 2022 年占据了最大的市场份额。基于横向流的免疫测定被广泛用于在医院、临床实验室和诊所中定量和定性检测各种抗体和抗原。它是一种简单且经济高效的分析方法,用于筛查、监测和诊断各种疾病。因此,横向流动免疫测定法的实用性极高;任何医疗专业人员和/或患者都可以在家中使用。

从应用方面来看,横向流动检测市场分为临床检测、兽医诊断、药物开发和质量检测以及食品安全和环境检测。临床检测领域在 2022 年占据了最大的市场份额。然而,药物开发和质量检测领域预计在预测期内将实现最高的复合年增长率。

根据最终用户,横向流动检测市场分为医院和诊所、诊断实验室、家庭护理、兽医诊所、制药和生物技术公司等。此外,医院和诊所部门在 2022 年占据最大市场份额。然而,制药和生物技术公司部门预计在预测期内将录得最高复合年增长率。

 

区域分析:

横向流动检测市场主要分为北美、欧洲、亚太地区、南美和中美以及中东和非洲。2022 年,北美占据了市场的大部分份额。同年,美国占据了该地区最大的市场份额。北美市场的增长特点是各种疾病的患病率不断上升、政府对先进诊断方法采用的支持以及市场参与者在研发和其他活动方面的不断努力。此外,诊断行业的技术进步很可能成为未来几年北美横向流动检测市场的主要驱动力。

美国卫生与公众服务部报告指出,美国约有 30–40% 的人患有幽门螺杆菌感染。同样,根据 PubMed Central (2020) 发表的一项研究,加拿大的幽门螺杆菌患病率估计在 20% 至 30% 之间。为了克服美国幽门螺杆菌的高患病率,各大顶级竞争者推出了基于横向流动免疫测定的创新产品,用于定性检测幽门螺杆菌抗原。例如,赛默飞世尔科技的创新产品“RAPID Hp StAR 横向流动试剂盒”可直接从粪便样本中检测幽门螺杆菌抗原。

此外,美国肝炎病毒感染率高,推动了侧流检测试剂盒的采用。根据《2020年病毒性肝炎监测报告》,美国每年有超过一万人感染肝炎。其中,急性丙型肝炎的发病率在过去十年中上升了124%,2020年比2019年上升了15%。

此外,加拿大生物技术行业的其他各种技术进步也增加了对基于横向流动检测的测试的需求。例如,2021 年 2 月,加拿大公司 Laipac Technology Inc. 与两家阿联酋公司 YAS Pharmaceuticals LLC 和 Pure Health LLC 合作,推出了首个由人工智能 (AI) 驱动的快速 COVID-19 抗原测试。2020 年 4 月,美国 Bio-Rad Laboratories 推出了一种基于血液的免疫测定试剂盒,用于识别 SARS-CoV-2 抗体。此外,公司正在加拿大分发用于幽门螺杆菌的检测试剂盒。例如,2021 年 6 月,Biomerica Inc. 宣布与一家加拿大合作伙伴达成一项为期五年的协议,该合作伙伴参与分销和营销一种名为 Biomerica hp+detect 的新型专有幽门螺杆菌测试。该测试旨在识别和监测幽门螺杆菌感染,这是十二指肠和胃溃疡的主要原因,也是与胃癌相关的一个危险因素。因此,上述因素支持北美市场的增长。

 

行业发展和未来机遇:

以下列出了全球横向流动分析市场的主要参与者采取的各种举措:

  1. 2023 年 3 月,罗氏宣布 FDA 批准 Ventana PD-L1(SP263)检测试剂盒,用于检测有资格接受 Regeneron 开发的 PD-1 抑制剂疗法 Libtayo 治疗的非小细胞肺癌患者。
  2. 2022 年 5 月,Bio-Rad Laboratories 推出了 CFX Duet 实时 PCR 系统,以支持研究人员开发单重和双重定量 PCR 检测。该系统提供该公司 CFX Opus 系统的强大热性能和专有的精确光学穿梭系统。
  3. 2021 年 4 月,Hologic 以约 7.95 亿美元收购了 Mobidiag Oy,这是一家私营的芬兰-法国分子诊断测试和仪器开发商。Hologic 打算投资于检测开发,以促进 Novodiag 平台的采用。Novodiag 系统结合了实时 PCR 和微阵列功能。
  4. 2020 年 4 月,Hologic 推出了一种新的 Aptima 分子检测方法,该方法在 Panther 系统上运行,用于检测 SARS-CoV-2。该系统是全自动的,具有高通量分子诊断平台,已在 60 个国家/地区和美国 50 个州安装。它可以在三小时内提供初步结果,每天可以处理 1,000 多次 COVID-19 测试。

 

横向流动分析市场报告范围

报告属性细节
2022 年市场规模85.1亿美元
2030 年的市场规模161.1亿美元
全球复合年增长率(2022 - 2030 年)8.4%
历史数据2020-2021
预测期2023-2030
涵盖的领域按产品类型
  • 试剂盒、试剂和横向流动读数仪
按技术分类
  • 夹心试验
  • 竞争性检测
  • 多重检测分析
按测试类型
  • 横向流动免疫分析和核酸横向流动分析
按应用
  • 临床试验
  • 兽医诊断
  • 食品安全及环境检测
  • 药物开发和质量测试
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  •  
  • 雅培实验室
  • F.霍夫曼-罗氏有限公司
  • 赛默飞世尔科技公司
  • Bio-Rad 实验室有限公司
  • 生物梅里埃公司
  • Quidel 公司
  • 霍洛吉奇公司
  • 珀金埃尔默公司
  • 默克公司
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

竞争格局和重点公司:

雅培实验室、F. Hoffmann-La Roche Ltd.、赛默飞世尔科技公司、Bio-Rad Laboratories, Inc.、bioMerieux SA、Quidel Corporation、PerkinElmer Inc.、Hologic Inc、默克集团、Becton, Dickinson and Company、西门子医疗集团和 QIAGEN 是横向流动检测市场的领先参与者。这些公司专注于推出新的高科技产品、改进现有产品和扩大地域范围,以满足全球日益增长的消费者需求。 

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the driving factors for the global lateral flow assay market worldwide?

The factors driving the market include increasing use of home-based assay kits and rising popularity of point-of-care testing. However, inconsistent assay results due to procedural limitations hinder the market growth.

Which segment is dominating the global lateral flow assay market?

The global lateral flow assay market, by product type, is segmented into Kits & Reagents and Lateral Flow Readers. The Kits & Reagents is expected to dominate the market owing to it is substantial rise in zoonotic and other animal diseases. Asia and Africa are among the hotspots for zoonoses—diseases transmitted from animals to humans. Thus, to meet the rising demand for diagnosing animal diseases, companies, including Thermo Fisher Scientific Inc; Bio-Rad Laboratories, Inc; and F. Hoffmann-La Roche AG, among others, offers various reagents and kits for sample collection, viral nucleic acid isolation, qualification and quantification for reliable and accurate SARS-CoV-2 testing, antimicrobial susceptibility testing, rabies diagnosis testing, qPCRs, FDA emergency use authorized RT-PCR detection kits in the market.

What are lateral flow assay?

Lateral flow assay is a type of diagnostic test that is used to detect the presence or absence of a target molecule in a sample. It is a simple and rapid testing method that does not require specialized equipment or technical expertise, making it suitable for point-of-care and home testing applications. Lateral flow assays are commonly used for various applications, including pregnancy tests, infectious disease diagnostics, food safety testing, and genetic testing. In genetic testing, lateral flow assays can be used to detect specific genetic mutations or sequences associated with various conditions or diseases.

Who are the major players in the global lateral flow assay market worldwide?

The global lateral flow assay market majorly consists of the players such as Abbott Laboratories, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., bioMerieux SA, Quidel Corporation, Hologic Inc, PerkinElmer Inc., Merck KGaA, Becton Dickinson and Co, Siemens Healthineers AG, and QIAGEN.

The List of Companies - Lateral Flow Assay Market 

  1. Abbott Laboratories
  2. F. Hoffmann-La Roche Ltd.
  3. Thermo Fisher Scientific Inc.
  4. Bio-Rad Laboratories, Inc.
  5. bioMerieux SA
  6. Quidel Corporation 
  7. Hologic Inc
  8. PerkinElmer Inc.
  9. Merck KGaA
  10. Becton Dickinson and Co
  11. Siemens Healthineers AG
  12. QIAGEN

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Biotechnology : READ MORE..